DATE

Media Contact:       

Cate Bonthuys 
Catalyst Comms
+44 7746 546773
bonthuys.cate@adlittle.com
 

Author team

ARTHUR D. LITTLE STRENGTHENS HEALTHCARE OFFERING IN CHINA WITH APPOINTMENT OF NEIL TANG

London, February, 22, 2024

Arthur D. Little (ADL) today announced that Neil Tang has joined the company as a Partner in its Shanghai office, where his main focus will be the Healthcare and Life Sciences practice. With 18 years of consulting experience, Neil has worked closely with many of the international and local pharmaceutical and life sciences companies based in China, with a particular focus on digital transformation and digital health as the Chinese market has rapidly developed.

Prior to joining ADL, he was a Partner at Deloitte Consulting, where he supported and advised both domestic and multinational pharma and biopharma companies on product launches, market access, and building digital eco-systems. Before then, Neil was Head of Strategy Consulting at Accenture Strategy & Consulting (S&C), Head of Consumer Health Consulting at IQVIA, Senior Manager at Kearney, and Associate Director at KPMG. He was also the co-founder and CEO of a successful e-commerce company.

Dereck Ji, Partner, China at ADL, comments, “With his impressive consultancy track record and close connections with many of China’s key healthcare and life sciences players, Neil is a great addition to our Shanghai office. Digital transformation is a high growth market opportunity in China – Neil’s entrepreneurial approach and strong expertise in designing, developing and launching digital platforms for pharma clients will be a real asset as we expand further into this sector. We warmly welcome him to the company.” 

Neil Tang, Partner at ADL, adds, “I’m excited to start working with ADL, because I enjoy coming up with innovative, change-making solutions in an entrepreneurial environment. As well as helping clients   to optimize their digital capabilities, I am particularly interested in helping life sciences and healthcare companies to develop digital health and digital therapeutics solutions that can directly improve outcomes for patients and consumers. This is a cutting edge area that requires consultancy that thinks outside of the box – working for ADL will enable me to deliver this type of innovative support.” 

Neil has has a Bachelor of Information Systems granted from the University of Technology, Sydney.

ARTHUR D. LITTLE STRENGTHENS HEALTHCARE OFFERING IN CHINA WITH APPOINTMENT OF NEIL TANG

DATE

London, February, 22, 2024

Arthur D. Little (ADL) today announced that Neil Tang has joined the company as a Partner in its Shanghai office, where his main focus will be the Healthcare and Life Sciences practice. With 18 years of consulting experience, Neil has worked closely with many of the international and local pharmaceutical and life sciences companies based in China, with a particular focus on digital transformation and digital health as the Chinese market has rapidly developed.

Prior to joining ADL, he was a Partner at Deloitte Consulting, where he supported and advised both domestic and multinational pharma and biopharma companies on product launches, market access, and building digital eco-systems. Before then, Neil was Head of Strategy Consulting at Accenture Strategy & Consulting (S&C), Head of Consumer Health Consulting at IQVIA, Senior Manager at Kearney, and Associate Director at KPMG. He was also the co-founder and CEO of a successful e-commerce company.

Dereck Ji, Partner, China at ADL, comments, “With his impressive consultancy track record and close connections with many of China’s key healthcare and life sciences players, Neil is a great addition to our Shanghai office. Digital transformation is a high growth market opportunity in China – Neil’s entrepreneurial approach and strong expertise in designing, developing and launching digital platforms for pharma clients will be a real asset as we expand further into this sector. We warmly welcome him to the company.” 

Neil Tang, Partner at ADL, adds, “I’m excited to start working with ADL, because I enjoy coming up with innovative, change-making solutions in an entrepreneurial environment. As well as helping clients   to optimize their digital capabilities, I am particularly interested in helping life sciences and healthcare companies to develop digital health and digital therapeutics solutions that can directly improve outcomes for patients and consumers. This is a cutting edge area that requires consultancy that thinks outside of the box – working for ADL will enable me to deliver this type of innovative support.” 

Neil has has a Bachelor of Information Systems granted from the University of Technology, Sydney.